Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Quinkert

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
JCI Insight|October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assemblyAngela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
Med (New York, N.Y.)|July 5, 2021
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccinationAngela M Minassian, Sarah E Silk, Jordan R Barrett, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
JCI Insight|October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assemblyAngela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
Med (New York, N.Y.)|July 5, 2021
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccinationAngela M Minassian, Sarah E Silk, Jordan R Barrett, et al.
Pageof 3